Xerox Holdings (XRX) shares rose 12% in Friday trading after alternative investment fund Starteepo Invest acquired 6.6 million shares of the business-equipment maker, representing a 5.05% stake.
Starteepo said Friday in a statement it "may engage in discussions with Xerox's management and board of directors regarding the company's business, strategy, capital structure, and opportunities to enhance shareholder value."
Price: $2.71, Change: $+0.28, Percent Change: +11.52%
eHealth (EHTH) has introduced a "prudent" three-year financial plan that should lead to mid-teens percentage growth in 2028,RBC Capital Markets said in a Thursday report."We view 2026 as a purposeful bridge year, with the company intentionally pulling back on marketing spend to prioritize cash flow generation and operational restructuring," the report said.The plan includes targets for mid-single digit revenue growth in 2027, driven by Medicare agency business and contribution from ancillary cross-selling with the lifetime advisory model, it said."While valuations sector-wide remain depressed followingpersistency headwinds and muted cash flow conversion, we are encouraged by the relative resiliency of eHealth's receivables," the note said.RBC kept its sector perform rating and $3 price target.Price: $1.75, Change: $-0.03, Percent Change: -1.97%
Natera (NTRA) said Friday the US Food and Drug Administration approved Signatera CDx as a companion diagnostic for use with adjuvant atezolizumab to treat muscle-invasive bladder cancer.The approval follows phase 3 trial results that showed Signatera molecular residual disease-positive patients treated with immunotherapy achieved improvements in disease-free survival and overall survival, while MRD-negative patients achieved 97% two-year OS with no adjuvant therapy, the company said.Price: $189.00, Change: $-7.91, Percent Change: -4.02%
Bill Ackman said Friday on the social media platform X that his Pershing Square hedge fund has sold Alphabet (GOOG, GOOGL) shares and established a new position in Microsoft (MSFT).Pershing began buying Microsoft in February after a notable share price decline following its fiscal Q2 results, acquiring a position at a valuation of 21 times forward earnings, in line with the market multiple and well below Microsoft's trading average over the last few years, Ackman said.Ackman said investors underestimate the resilience of the Microsoft 365 franchise given its embedded role across enterprises and highly attractive price-to-value proposition, according to the X post.Concerns regarding the growth trajectory of Microsoft's Azure cloud business are similarly misplaced, especially after the franchise's exceptional recent performance, he added."We believe that $MSFT offers analogous and compelling long-term value at today's valuation," Ackman said on X.Price: $392.13, Change: $-5.04, Percent Change: -1.27%